<code id='6A5D9504B9'></code><style id='6A5D9504B9'></style>
    • <acronym id='6A5D9504B9'></acronym>
      <center id='6A5D9504B9'><center id='6A5D9504B9'><tfoot id='6A5D9504B9'></tfoot></center><abbr id='6A5D9504B9'><dir id='6A5D9504B9'><tfoot id='6A5D9504B9'></tfoot><noframes id='6A5D9504B9'>

    • <optgroup id='6A5D9504B9'><strike id='6A5D9504B9'><sup id='6A5D9504B9'></sup></strike><code id='6A5D9504B9'></code></optgroup>
        1. <b id='6A5D9504B9'><label id='6A5D9504B9'><select id='6A5D9504B9'><dt id='6A5D9504B9'><span id='6A5D9504B9'></span></dt></select></label></b><u id='6A5D9504B9'></u>
          <i id='6A5D9504B9'><strike id='6A5D9504B9'><tt id='6A5D9504B9'><pre id='6A5D9504B9'></pre></tt></strike></i>

          Home / comprehensive / leisure time

          leisure time


          leisure time

          author:fashion    Page View:78
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In